IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024 March 20, 2024 Read More »
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline March 12, 2024 Read More »
IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a Buy Recommendation and $3.00 Price Target February 23, 2024 Read More »
IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s January 23, 2024 Read More »
IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial January 17, 2024 Read More »
Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s December 19, 2023 Read More »
IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024 December 13, 2023 Read More »
